Tissue expression
Cell line expression
Protein structure
BCCIP
BRCA2 and CDKN1A interacting proteinBCCIPalpha, TOK-1
This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Top validated antibodies |
|||||
Proteintech Group | 16043-1-AP | 5 references | Polyclonal |
WB
EL
ICC
IP |
|
Invitrogen Antibodies | 16043-1-AP | Polyclonal |
WB
ICC
IP
IHC
OA
|
||
LSBio | LS-C186295 | Polyclonal |
WB
ICC
IHC
|
||
Biorbyt | orb1939870 | Polyclonal |
WB
EL
ICC
IHC
FC
|
||
Novus Biologicals | NBP1-31319 | Polyclonal |
WB
ICC
IP
IHC |
All Antibodies
Filters
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider